PARIS, Oct. 1 /PRNewswire/ -- Fovea Pharmaceuticals announced today that it has entered into a binding agreement with sanofi-aventis to sell 100% of its share to sanofi-aventis. Fovea has a portfolio ...
Sanofi-aventis poursuit sa stratégie d’acquisitions et annonce aujourd’hui la signature d’un accord en vue de l’acquisition de Fovea, une société biopharmaceutique française de recherche et ...
Findings from a post hoc analysis of the AREDS and AREDS2 studies were presented at the recent American Academy of Ophthalmology (AAO) meeting, showing that use of AREDS supplements may reduce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback